<DOC>
	<DOCNO>NCT00667745</DOCNO>
	<brief_summary>This study evaluate whether lithium include part optimize medication treatment improve overall level illness , symptom mania depression , quality life people bipolar disorder .</brief_summary>
	<brief_title>Effectiveness Lithium Plus Optimized Medication Treating People With Bipolar Disorder</brief_title>
	<detailed_description>Bipolar illness , brain disorder cause dramatic change person 's mood energy , affect 2.6 % adult United States . Bipolar disorder characterize cyclical period extreme high low , know episode mania depression . A person undergoing episode mania often experience euphoric mood , increase energy , aggressive behavior , person depressed state often experience low mood , lack energy , feeling sadness . Lithium widely use mood stabilize medication show reduce occurrence intensity manic episode may lessen depressive episode well . Including lithium part personalize medication treatment approach may effective mean improve symptom bipolar disorder . This study evaluate whether lithium include part optimize medication treatment improve overall level illness , symptom mania depression , quality life people bipolar disorder . Participation study last 6 month . All participant initial assessment include interview questionnaire confirm diagnosis bipolar disorder , vital sign measurement , blood draw , female , pregnancy . Eligible participant assign randomly receive either optimized medication plus lithium optimized medication without lithium . Participants group receive 6 month monitor treatment medication regimen , prescribe study doctor . Participants attend study visit every 2 week first 8 week month 4 month . These visit last 45 60 minute include medication adjustment question symptom , side effect , quality life . We would like acknowledge medication kindly donate Ortho-McNeil Janssen Scientific Affairs , LLC .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Lithium Carbonate</mesh_term>
	<criteria>Meets DSMIV Criteria bipolar disorder ( type I II ) Currently symptomatic , defined Clinical Global Impressions ScaleBipolar Version , Overall Severity Index ( CGIBPS ) great equal 3 If take take lithium , must lithium least 30 day study entry If woman child bear potential , agree inform doctor early possible time plan conceive , use adequate contraception ( e.g . oral contraceptive , intrauterine device , barrier method , total abstinence intercourse ) , acknowledge risk lithium fetus infant ( Depo Provera acceptable start 3 month study entry ) Renal impairment ( serum creatinine great 1.5 mg/dL ) Thyroid stimulate hormone ( TSH ) 20 % upper normal limit ( participant maintain thyroid medication must euthyroid least 3 month Visit 1 ) History lithium toxicity cause mismanagement overdose Other contraindication lithium ( e.g. , hypersensitivity lithium component formulation , severe cardiovascular renal disease , severe debilitation , dehydration , sodium depletion , pregnancy ) Currently crisis inpatient hospitalization crisis Participated clinical trial investigational drug within 1 month study entry Pregnant breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>Lithium</keyword>
	<keyword>Symptoms</keyword>
	<keyword>Medication Changes</keyword>
</DOC>